Choosing between Pharmacy and Biotechnology after Class 12 requires understanding their distinct career paths. Pharmacy ...

Explore Q3 market performance, fund underperformance, and the transformative power of AI. Uncover our strategy for long-term growth and adaptability. Read the full report!

The Dubai Genome Program sequenced almost one million UAE citizens’ genomes by mid-2024. One million. That’s a ...

The Fund mostly kept pace with its core MSCI EAFE benchmark in Q3, with our sector positioning in IT and financials, which ...

The Innovation Lab at Edison High has been expanded to rescue and house endangered southern steelhead trout, and a ribbon-cutting ceremony was held Thursday.

The wait is over for more than 15,000 Tasmanian grade 11 and 12 students who received their academic results on Wednesday.

HELIOS-B is a global, randomized, double-blind, placebo-controlled clinical trial that evaluated the efficacy and safety of AMVUTTRA (R) in adult patients with wtATTR or hATTR amyloidosis with ...

Guggenheim Securities served as lead financial advisor to Harvard Bioscience in connection with the transaction. Covington & Burling LLP acted as legal advisor to Harvard Bioscience, and Cooley LLP ...

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...

Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial FlexibilityBroadOak Partner Bill Snider to Join Board of Directors and Company to Form Advisory Board on ...

NetraMark Holdings Inc. (the "Company" or "NetraMark") a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical ...

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who ...